title: The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
authors.forename: Homayoon
authors.initials: H
authors.lastname: Khanlou
authors.forename: Susan
authors.initials: S
authors.lastname: Sanchez
authors.forename: Michele
authors.initials: M
authors.lastname: Babaie
authors.forename: Catherine
authors.initials: C
authors.lastname: Chien
authors.forename: Gerald
authors.initials: G
authors.lastname: Hamwi
authors.forename: Juan-Carlos
authors.initials: JC
authors.lastname: Ricaurte
authors.forename: Tomiko
authors.initials: T
authors.lastname: Stein
authors.forename: Laveeza
authors.initials: L
authors.lastname: Bhatti
authors.forename: Paul
authors.initials: P
authors.lastname: Denouden
authors.forename: Charles
authors.initials: C
authors.lastname: Farthing
mesh_terms: D000328:Adult; D000368:Aged; D000554:Ambulatory Care Facilities; D000914:Antibodies, Viral / Q000097:blood; D002140:California / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D007271:Injections, Intradermal; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines